US Patent Issued to National University of Singapore, St. Jude Children's Research Hospital on April 1 for "Natural killer cells expressing membrane-bound interleukin 15 (mbIL15) and uses thereof" (Singaporean, American, Japanese Inventors)

ALEXANDRIA, Va., April 2 -- United States Patent no. 12,264,335, issued on April 1, was assigned to National University of Singapore (Singapore) and St. Jude Children's Research Hospital Inc. (Tennessee, Tunisia).

"Natural killer cells expressing membrane-bound interleukin 15 (mbIL15) and uses thereof" was invented by Dario Campana (Singapore), David Shook (Memphis, Tenn.) and Masaru Imamura (Chuo-ku, Japan).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present invention provides, in certain aspects, a natural killer (NK) cell that expresses all or a functional portion of interleukin-15 (IL-15), and methods for producing such cells. The invention further provides methods of using a natural killer (NK) ce...